Clinical Trials Directory

Trials / Unknown

UnknownNCT03184727

Pulmonary Vasculature and Right Heart Dysfunction in Chronic Obstructive Pulmonay Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

The pulmonary vasculopathy and right heart dysfunction in COPD are drawing increasing attention these days. Recent researches show that pulmonary vasculopathy and right heart dysfunction relate to greater severity in COPD. Applying appropriate modalities for early detection of pulmonary vasculopathy and right heart dysfunction is of great importance. What's more, the interaction mechanism between pulmonary vasculature, right heart and COPD still needs to be further studied. The aim of our study is to develop an assessment system of pulmonary vasculopathy and right heart dysfunction in COPD patients and elucidate their impact on COPD course and outcome.

Conditions

Timeline

Start date
2017-06-15
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2017-06-14
Last updated
2017-06-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03184727. Inclusion in this directory is not an endorsement.